Back to today’s briefing

Story perspectives

Over 1,000 Women Sue Pfizer for Tumor Risks

10/1/2025

41 9

Summary

Story summary

Over 1,000 U.S. women sue Pfizer over Depo-Provera-related brain tumors.
The consolidated multidistrict litigation (MDL) could reach 5,000–10,000 cases; a Pensacola, Florida court will decide.
Plaintiffs say Pfizer failed to warn about tumor risk and misled the FDA.
Studies show higher meningioma risk with prolonged Depo-Provera use; Australia’s regulator approved a warning in 2024, but warnings remain inadequate.

1 of 1

Story summary

Over 1,000 U.S. women sue Pfizer over Depo-Provera-related brain tumors.
The consolidated multidistrict litigation (MDL) could reach 5,000–10,000 cases; a Pensacola, Florida court will decide.
Plaintiffs say Pfizer failed to warn about tumor risk and misled the FDA.
Studies show higher meningioma risk with prolonged Depo-Provera use; Australia’s regulator approved a warning in 2024, but warnings remain inadequate.